Drugs Health Pharma

Vampiric tumour cells can hijack human body’s immune cell energy

HQ Team November 22, 2023: Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the.

Read More
Climate Health Medical

Uncovering hidden costs of lead exposure: New study

HQ Team November 21, 2023: Lead exposure remains a significant worldwide health risk, and a study has quantified its toll on both health.

Read More
Drugs Medical Pharma

Zevra Therapeutics completes acquisition of Acer in a $91m deal

HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition.

Read More
Drugs Health Pharma

Opinion: Food poisoning, deaths took shawarma out of my food menu

By Dr. K. Leelamoni November 21, 2023: Shawarma was a favourite dish of mine and I first came to know about it when.

Read More
Drugs Health Medical

New therapy shows promise in restoring smell and taste for long Covid

HQ Team November 20, 2023: A new study suggests that targeting the stellate ganglion, known as a “stellate ganglion block,” could restore smell.

Read More
Drugs Medical Pharma

Bayer aborts late-stage trial of anticoagulant drug due to inefficacy

HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian..

Read More
Health Medical Pharma

Micron gets $23.6m Gates Foundation grant to make needle-free vaccines

HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.

Read More
Drugs Health Pharma

Lilly to build $2.5b plant in Germany to make diabetes, obesity devices

HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.

Read More
Drugs Health Pharma

Astellas’ prostate cancer drug for metastasis-free survival gets nod

HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of.

Read More
Health Medical Pharma

WHO rejects setting up ‘safe zone’ in Gaza, says ‘broad agreement’ needed

HQ Team November 18, 2023: A plan to create a safe zone at Gaza’s Al-Mawasi is a “recipe for disaster” and the WHO.

Read More